Virtu Financial’s SELLAS Life Sciences SLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-53,861
| Closed | -$58K | – | 1999 |
|
|
2025
Q1 | $58K | Buy |
53,861
+12,706
| +31% | +$13.7K | ﹤0.01% | 995 |
|
|
2024
Q4 | $43K | Sell |
41,155
-38,086
| -48% | -$39.8K | ﹤0.01% | 1184 |
|
|
2024
Q3 | $99K | Buy |
79,241
+15,398
| +24% | +$19.2K | 0.01% | 913 |
|
|
2024
Q2 | $76K | Buy |
63,843
+24,414
| +62% | +$29.1K | 0.01% | 858 |
|
|
2024
Q1 | $40K | Sell |
39,429
-20,485
| -34% | -$20.8K | ﹤0.01% | 1057 |
|
|
2023
Q4 | $64K | Buy |
59,914
+40,952
| +216% | +$43.7K | 0.01% | 1133 |
|
|
2023
Q3 | $31K | Buy |
+18,962
| New | +$31K | ﹤0.01% | 954 |
|
|
2023
Q1 | – | Sell |
-18,379
| Closed | -$43K | – | 2052 |
|
|
2022
Q4 | $43K | Buy |
+18,379
| New | +$43K | 0.01% | 1113 |
|
|
2022
Q1 | – | Sell |
-13,935
| Closed | -$77K | – | 1989 |
|
|
2021
Q4 | $77K | Buy |
+13,935
| New | +$77K | 0.01% | 1227 |
|
|
2021
Q2 | – | Sell |
-14,593
| Closed | -$125K | – | 2029 |
|
|
2021
Q1 | $125K | Sell |
14,593
-4,855
| -25% | -$41.6K | 0.01% | 1244 |
|
|
2020
Q4 | $113K | Buy |
+19,448
| New | +$113K | 0.01% | 1028 |
|
|
2020
Q3 | – | Sell |
-33,296
| Closed | -$98K | – | 1468 |
|
|
2020
Q2 | $98K | Buy |
+33,296
| New | +$98K | 0.01% | 885 |
|
|
2018
Q3 | – | Sell |
-240
| Closed | -$41K | – | 2114 |
|
|
2018
Q2 | $41K | Buy |
240
+13
| +6% | +$2.22K | ﹤0.01% | 1788 |
|
|
2018
Q1 | $39K | Buy |
227
+211
| +1,319% | +$36.3K | ﹤0.01% | 1750 |
|
|
2017
Q4 | $6K | Buy |
16
+3
| +23% | +$1.13K | ﹤0.01% | 2277 |
|
|
2017
Q3 | $7K | Buy |
+13
| New | +$7K | ﹤0.01% | 2423 |
|